How is NAD+ injection dosed and mixed?

Draw to

unitsmL

0.3 mL · 30 units syringe0.5 mL · 50 units syringe1 mL · 100 units syringe3 mL · 3cc syringe0.5 mL · 20 units, U-40 syringe1 mL · 40 units, U-40 syringe

051015202530 01020304050 0102030405060708090100 00.511.522.53 05101520 010203040

    mL
    Most often logged by Milligram users
    Syringe scale
    Syringe

    Concentration is the powder in the vial divided by the water. The draw is the dose divided by the concentration, in mL, times 100 on a U-100 syringe or 40 on a U-40. Every figure comes from what you enter.

    Save to Milligram
    How often

    Open in Milligram shows once the calculator has a result.

    Open in Milligram is off while the dose is more than the whole vial. Check the dose and its unit.

    Open in Milligram is off while the draw is under one unit. Check the dose and its unit.

    Open in Milligram adds NAD+ and this dose to a plan in the app, with the schedule you pick here. The vial and water are not saved.

    A DailyMed search returned no US label for an injectable NAD+; Yu, a randomised trial in 180 adults with heart failure from ischaemic cardiomyopathy, gave 10 mg a day by vein for 7 days against placebo,1 and of the people who logged NAD+ doses, 32% logged 50 mg.10

    The guide's example

    50 mg of NAD+ (Nicotinamide Adenine Dinucleotide) from a 500 mg vial mixed with 5 mL is 50 units on a U-100 syringe.

    Every vial at a glance. Pick a cell to draw it on the syringe.

    Concentration is the vial's amount over its water; units are the dose over the concentration, times 100, on a U-100 syringe.
    Vial3 mL of water5 mL of water10 mL of water
    500 mg48% set up10166.667 mg/mL: 25 mg is 15 units, 50 mg is 30 units, 100 mg is 60 units100 mg/mL: 25 mg is 25 units, 50 mg is 50 units, 100 mg is 100 units50 mg/mL: 25 mg is 50 units, 50 mg is 100 units, 100 mg is over 1 mL
    1,000 mg40% set up10333.333 mg/mL: 25 mg is 7.5 units, 50 mg is 15 units, 100 mg is 30 units200 mg/mL: 25 mg is 12.5 units, 50 mg is 25 units, 100 mg is 50 units100 mg/mL: 25 mg is 25 units, 50 mg is 50 units, 100 mg is 100 units

    Most often logged by Milligram users: 50 mg, 32% logged.10

    Jump to a vial 500 mg 1,000 mg

    Vials, water and syringe marks

    Of the people who logged NAD+ vials, 48% set up 500 mg and 40% set up 1,000 mg.10 The mixes people set up included 500 mg with 5 mL (17%) and 500 mg with 3 mL (14%).10

    No label or manufacturer leaflet found for injectable NAD+ powder states which water or how much. In Reyna, a retrospective review of 6 clinic clients given NAD+ by vein, nurses reconstituted 500 mg of powder with bacteriostatic water as the supplier directed, volume not given, then diluted it in 500 mL of normal saline.2 NCT06919328, a registered trial recruiting 70 people with no results posted, lists 100 mg of NAD+ in 2 mL of bacteriostatic water under the skin, as the comparator to nicotinamide riboside.3

    A 500 mg vial mixed with 5 mL is 100 mg/mL, so 50 mg is 50 units on a U-100 syringe. Of the people who logged a mark, 9% logged 50 mg at 50 units.10

    50 mg of NAD+ (Nicotinamide Adenine Dinucleotide) from a 500 mg vial mixed with 5 mL is 50 units on a U-100 syringe.

    The calculator is at the top of the page

    Doses and schedules reported

    The only US nadide label a DailyMed search found is for an oral homeopathic product, a 500 mg powder in a 10 mL vial, not an injection.4 The published trials below gave NAD+ by vein or into muscle; the only registered subcutaneous NAD+ arm found, in NCT06919328, is recruiting and has posted no results.3

    TrialDose and schedulePeopleLength
    Grant, randomised pilot5750 mg by vein over 6 hours in one infusion, against salineEleven healthy men aged 30 to 55: 8 given NAD+, 3 given saline6 hours
    Reyna, retrospective clinic review2500 mg by vein once a day, against 500 mg of nicotinamide riboside6 clients on NAD+, 8 on nicotinamide ribosideFour days
    Yu, heart failure110 mg a day by vein, against placebo180 adults with heart failure from ischaemic cardiomyopathy7 days
    Yu, heart attack610 mg a day by vein, against placebo120 people with STEMI treated by primary PCI7 days
    NCT06919328, recruiting, no results3100 mg in 2 mL of bacteriostatic water under the skin, as the comparator to nicotinamide riboside70 plannedNot stated
    Gao, sudden hearing loss75 mg in 2 mL of saline into muscle daily, with standard treatmentNAD+ plus standard treatment (18 people) and standard treatment alone (20 people)Daily during inpatient treatment, a median of 7 days (range 4 to 13)

    Of the people who logged NAD+ doses, 32% set up 50 mg, and 13% each set up 25 mg and 100 mg.10

    Storage

    Before mixing, an injectable Chinese NAD+ powder in 5 mg vials is stored protected from light at no more than 20 °C, with a 24-month shelf life, as the protocol of NCT07839130, a planned paediatric trial, restates the maker's conditions.8 The oral homeopathic powder label gives 2 to 8 °C short term and minus 15 to minus 25 °C long term.4 A search of labels, regulator documents and trials returned no storage time or temperature for NAD+ after mixing.

    Frequently asked questions

    When to take NAD+ and how often?

    In Yu, the heart failure trial of 180 adults, 10 mg was dissolved in 100 mL of 5% glucose solution (or normal saline for people with diabetes) and given by vein once a day for 7 consecutive days.1 NCT06558253, a registered phase 1 dose-escalation trial in 12 people after cord blood transplant, gave 21 consecutive days of infusion by vein, in three dose groups of 10 mg, 20 mg and 50 mg a day.9

    Which route do people log for NAD+?

    Of the people who logged a route, 95% logged under the skin.10

    How the logged figures are counted

    Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.

    References

    1. American Journal of Cardiovascular Drugs. Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial. 2026. pmc.ncbi.nlm.nih.gov
    2. Frontiers in Aging. Intravenous infusion of NAD+ versus nicotinamide riboside: a retrospective tolerability pilot study in a real-world setting. 2026. pmc.ncbi.nlm.nih.gov
    3. ClinicalTrials.gov. Absorption and Tolerability of Injectable Administration of Niagen+, as Compared to NAD+ (NCT06919328). 2025. clinicaltrials.gov
    4. US National Library of Medicine (DailyMed), label text by Viatrexx Bio Incorporated. Viatrexx-NAD Plus (nadide) powder, DailyMed listing. 2019. dailymed.nlm.nih.gov
    5. Frontiers in Aging Neuroscience. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. 2019. pmc.ncbi.nlm.nih.gov
    6. American Journal of Cardiovascular Drugs. Effect of Intravenous NAD on Left Ventricular Function After Primary PCI in STEMI (PubMed abstract). 2026. pubmed.ncbi.nlm.nih.gov
    7. The Laryngoscope. NAD+ Enhanced on Hearing Recovery in Sudden Sensorineural Hearing Loss: Randomized Controlled Trial. 2026. pmc.ncbi.nlm.nih.gov
    8. ClinicalTrials.gov. PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide (NCT07839130). 2026. clinicaltrials.gov
    9. ClinicalTrials.gov. Coenzyme I for Injection in Hematopoietic Recovery After Cord Blood Transplant (NCT06558253). 2024. clinicaltrials.gov
    10. Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted